These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 30306276)

  • 21. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
    Rottoli M; Vallicelli C; Boschi L; Poggioli G
    Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer.
    Rausa E; Kelly ME; Bonavina L; O'Connell PR; Winter DC
    Colorectal Dis; 2017 May; 19(5):430-436. PubMed ID: 28267255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
    Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
    J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes?
    Colibaseanu DT; Dozois EJ; Mathis KL; Rose PS; Ugarte ML; Abdelsattar ZM; Williams MD; Larson DW
    Dis Colon Rectum; 2014 Jan; 57(1):47-55. PubMed ID: 24316945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pelvic exenteration for recurrent rectal cancer.
    Avradopoulos KA; Vezeridis MP; Wanebo HJ
    Adv Surg; 1996; 29():215-33. PubMed ID: 8720005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
    Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
    ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excision of the seminal vesicles for locally advanced and recurrent rectal and sigmoid cancer.
    Keating JP; Manning S; Dennett E; Studd R
    ANZ J Surg; 2017 Sep; 87(9):688-691. PubMed ID: 25827193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
    Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended pelvic resection for rectal and anal canal tumors is a significant risk factor for perineal wound infection: a retrospective cohort study.
    Imaizumi K; Nishizawa Y; Ikeda K; Tsukada Y; Sasaki T; Ito M
    Surg Today; 2018 Nov; 48(11):978-985. PubMed ID: 29858669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. R0 resection, not surgical technique, is the key consideration in pelvic exenteration surgery.
    Warren OJ; Solomon MJ
    Tech Coloproctol; 2015 Feb; 19(2):117-8. PubMed ID: 25544128
    [No Abstract]   [Full Text] [Related]  

  • 33. Systematic Review of Pelvic Exenteration With En Bloc Sacrectomy for Recurrent Rectal Adenocarcinoma: R0 Resection Predicts Disease-free Survival.
    Sasikumar A; Bhan C; Jenkins JT; Antoniou A; Murphy J
    Dis Colon Rectum; 2017 Mar; 60(3):346-352. PubMed ID: 28177998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
    Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127
    [No Abstract]   [Full Text] [Related]  

  • 35. The Impact of Tumour Distance From the Anal Verge on Clinical Management and Outcomes in Patients Having a Curative Resection for Rectal Cancer.
    Khan MAS; Ang CW; Hakeem AR; Scott N; Saunders RN; Botterill I
    J Gastrointest Surg; 2017 Dec; 21(12):2056-2065. PubMed ID: 28924962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transsacral exenteration of fixed primary and recurrent anorectal cancer.
    Gonzalez RJ; McCarter MD; McDermott T; Pearlman NW
    Am J Surg; 2003 Dec; 186(6):670-4. PubMed ID: 14672777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer.
    Gould LE; Pring ET; Drami I; Moorghen M; Naghibi M; Jenkins JT; Steele CW; Roxburgh CS
    Int J Surg; 2022 Aug; 104():106738. PubMed ID: 35781038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined laparoscopic and transperineal endoscopic total pelvic exenteration for local recurrence of rectal cancer.
    Hasegawa S; Kajitani R; Matsumoto Y; Ohmiya T; Nagano H; Komono A; Aisu N; Yoshimatsu G; Yoshida Y
    Tech Coloproctol; 2020 Jun; 24(6):599-601. PubMed ID: 32236744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gracilis muscle flaps for covering losses of perineal substance in cancer surgery].
    de Ranieri J; Crouet H; André M; Ollivier JM; Desdoits JM; Bouvet A; Souloy J
    Presse Med; 1985 Nov; 14(38):1967-9. PubMed ID: 2933710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer.
    van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ
    Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.